DE69309540T2 - Orale Arzneimittel mit kolonspezifischer Freisetzung - Google Patents

Orale Arzneimittel mit kolonspezifischer Freisetzung

Info

Publication number
DE69309540T2
DE69309540T2 DE69309540T DE69309540T DE69309540T2 DE 69309540 T2 DE69309540 T2 DE 69309540T2 DE 69309540 T DE69309540 T DE 69309540T DE 69309540 T DE69309540 T DE 69309540T DE 69309540 T2 DE69309540 T2 DE 69309540T2
Authority
DE
Germany
Prior art keywords
core
oral drug
coating layer
colon release
intermediate coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69309540T
Other languages
English (en)
Other versions
DE69309540D1 (de
DE69309540T3 (de
Inventor
Stefano Poli
Cesare Busetti
Luigi Moro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polichem SA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11363431&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69309540(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Publication of DE69309540D1 publication Critical patent/DE69309540D1/de
Publication of DE69309540T2 publication Critical patent/DE69309540T2/de
Application granted granted Critical
Publication of DE69309540T3 publication Critical patent/DE69309540T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69309540T 1992-06-01 1993-05-28 Orale Arzneimittel mit kolonspezifischer Freisetzung Expired - Lifetime DE69309540T3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921347A IT1260505B (it) 1992-06-01 1992-06-01 Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon

Publications (3)

Publication Number Publication Date
DE69309540D1 DE69309540D1 (de) 1997-05-15
DE69309540T2 true DE69309540T2 (de) 1997-09-04
DE69309540T3 DE69309540T3 (de) 2001-03-15

Family

ID=11363431

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69309540T Expired - Lifetime DE69309540T3 (de) 1992-06-01 1993-05-28 Orale Arzneimittel mit kolonspezifischer Freisetzung

Country Status (8)

Country Link
EP (1) EP0572942B2 (de)
AT (1) ATE151285T1 (de)
DE (1) DE69309540T3 (de)
DK (1) DK0572942T4 (de)
ES (1) ES2101164T5 (de)
GR (2) GR3023605T3 (de)
HU (1) HUT75158A (de)
IT (1) IT1260505B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
NL1009107C2 (nl) 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CN1499960A (zh) 2001-03-13 2004-05-26 ����˹��ҩ�﹫˾ 时间治疗剂型
FR2830446B1 (fr) * 2001-10-09 2004-02-06 Univ Pasteur Composition pharmaceutique destinee a liberer une substance active au niveau du colon
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
CU23334A1 (es) * 2003-03-20 2008-12-24 Inst Finlay Vacuna de vibrio cholerae inactivada en tabletas
JP2007505921A (ja) 2003-09-19 2007-03-15 ペンウェスト ファーマシューティカルズ カンパニー 遅延放出剤形
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
ITMI20041295A1 (it) 2004-06-25 2004-09-25 Cosmo Spa Composizioni farmaceutiche antimicrobiche orali
EP1754471A1 (de) * 2005-08-18 2007-02-21 ORAMON-Arzneimittel GmbH & Co. KG Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
CN102105140B (zh) * 2008-07-02 2013-10-23 巴斯夫欧洲公司 涂覆片剂的方法
IT1393244B1 (it) 2008-07-18 2012-04-12 Universita' Degli Studi Di Milano Sistema per il rilascio al colon di farmaci suscettibili di degradazione enzimatica e/o scarsamente assorbiti nel tratto gastrointestinale
JP5719312B2 (ja) 2009-01-14 2015-05-13 ノヴァクタ バイオシステムズ リミティッド デオキシアクタガルジン誘導体
CA2750883A1 (en) 2009-02-04 2010-08-12 Novacta Biosystems Limited Actagardine derivatives
WO2015161139A1 (en) 2014-04-16 2015-10-22 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
CA2805445C (en) 2010-07-29 2018-05-01 Cosmo Technologies Ltd. Pharmaceutical and/or dietary compositions based on short chain fatty acids
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
JP6049938B2 (ja) 2013-04-05 2016-12-21 ポリケム・エスエイ 過敏腸管症候群を治療するためのピドチモドの使用
EP3089737B1 (de) 2013-12-31 2021-11-03 Rapamycin Holdings, LLC Orale rapamycinnanopartikelzubereitungen und verwendung
CN105943505A (zh) * 2016-05-26 2016-09-21 杭州百诚医药科技股份有限公司 一种匹多莫德药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
IT1230576B (it) 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5032406A (en) † 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
DK469989D0 (da) † 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
HUT75158A (en) 1997-04-28
DK0572942T4 (da) 2001-01-22
GR3035415T3 (en) 2001-05-31
DE69309540D1 (de) 1997-05-15
ITMI921347A1 (it) 1993-12-02
ATE151285T1 (de) 1997-04-15
DE69309540T3 (de) 2001-03-15
HU9301577D0 (en) 1993-09-28
GR3023605T3 (en) 1997-08-29
EP0572942A2 (de) 1993-12-08
EP0572942B2 (de) 2000-11-29
ES2101164T3 (es) 1997-07-01
ES2101164T5 (es) 2001-02-01
ITMI921347A0 (it) 1992-06-01
EP0572942B1 (de) 1997-04-09
DK0572942T3 (da) 1997-10-20
IT1260505B (it) 1996-04-09
EP0572942A3 (en) 1994-08-24

Similar Documents

Publication Publication Date Title
DE69309540T2 (de) Orale Arzneimittel mit kolonspezifischer Freisetzung
ATE112961T1 (de) Cimetidin enthaltende arzneimittel.
SE9102072D0 (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
ITMI942484A0 (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
ATE217789T1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
DK0637236T3 (da) Farmaceutisk præparat og fremgangsmåde til dets fremstilling
NO176305C (no) Fremgangsmåte for fremstilling av orale legemiddelformer av pimobendan
DK0876388T3 (da) Tricykliske erythromycinderivater
ITFI930030A0 (it) Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizione farmaceutiche che li contengo-no.
NO942952L (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
ATE149827T1 (de) Feste arzneimitteldosierungsform und methode zur verminderung des abriebs
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
ITMI942483A0 (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
ATE59551T1 (de) Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung.
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
ES2032476T3 (es) Un procedimiento para preparar nuevos derivados de 2-anilinotiazolina.
ES2127305T3 (es) Una forma farmaceutica para la administracion rectal de compuestos farmacologicamente activos.
FR2702960B1 (fr) Leurre pour l'administration orale de médicaments vétérinaires.
ITMI931049A1 (it) Composizione farmaceutica mucoadesiva a rilascio controllato per la somministrazione orale di furosemide
ATA172297A (de) Pharmazeutische orale zusammensetzung enthaltend fk506
TH59041A (th) รูปแบบขนาดสารทางเภสัชศาสตร์ที่มีการปลดปล่อยนานสำหรับให้ทางปาก

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: POLICHEM S.A., LUXEMBURG/LUXEMBOURG, LU

8366 Restricted maintained after opposition proceedings